Grant: CIHR Fellowship
University of Toronto
$135,000.00
Evolutionarily optimized antimicrobial combinations and vesicle delivery systems from environmental actinomycetes
EF 2020-21
Résumé
Environmental bacteria make many interesting chemicals to more effectively grow in their environment and to compete with other microbes. We have adapted these chemicals for use as antibiotics and many other types of medications. Unfortunately, many antibiotics are losing their effectiveness because the bacteria that cause human infections are becoming resistant. Environmental bacteria still have many chemicals and strategies for us to discover and adapt as new treatment options. Recent research suggests that in the environment, bacteria enhance the effect of the chemicals they make by packaging them into membrane bound parcels - extracellular vesicles - to enable their chemicals to travel farther and to target specific competitors. Moreover, not just one, but combinations of chemicals that have improved effects together are produced. We are isolating these vesicles, studying how the bacteria load chemicals into them, and determining how these vesicles and combination chemicals improve killing of pathogenic bacteria. By taking these new approaches to antibiotic discovery we will be able to find new drug leads and drug delivery mechanisms to help combat the clinical problem of antibiotic resistance.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
441091
Name
Meyer Kirsten J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Evolutionarily optimized antimicrobial combinations and vesicle delivery systems from environmental actinomycetes
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antibiotic Combinations; Antibiotic Resistance; Drug Discovery; Extracellular Vesicles; Streptomyces Bacteria
Abstract
Environmental bacteria make many interesting chemicals to more effectively grow in their environment and to compete with other microbes. We have adapted these chemicals for use as antibiotics and many other types of medications. Unfortunately, many antibiotics are losing their effectiveness because the bacteria that cause human infections are becoming resistant. Environmental bacteria still have many chemicals and strategies for us to discover and adapt as new treatment options. Recent research suggests that in the environment, bacteria enhance the effect of the chemicals they make by packaging them into membrane bound parcels - extracellular vesicles - to enable their chemicals to travel farther and to target specific competitors. Moreover, not just one, but combinations of chemicals that have improved effects together are produced. We are isolating these vesicles, studying how the bacteria load chemicals into them, and determining how these vesicles and combination chemicals improve killing of pathogenic bacteria. By taking these new approaches to antibiotic discovery we will be able to find new drug leads and drug delivery mechanisms to help combat the clinical problem of antibiotic resistance.
Competitiondate
202012
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Meyer, Kirsten J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~